Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $12.26 + 0.15 (1.24%)
ExchangeNASDAQ GS
Volume49,145
Today's Open$12.22
Previous Close$12.11
Data as of 08/25/16 3:59 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $12.26 with a 52 week high of $21.00 and a 52 week low of $9.79.
Recent News

August 09, 2016

NantHealth Reports Strong 2016 Second-Quarter Revenues and Continued Progress on GPS Cancer and NantOS Platform

Total Quarterly Net Revenues Increased 167% to $31.5 Million from $11.8 Million Total Six-Month Net Revenues More than Doubled to $50.9 Million from $23.5 Million Raised Net Proceeds of Approximately $83.2 Million from Successful IPO in June 2016 GPS Progress: Increased to 200,000 Covered Cancer Lives with Three New Payer Agreements, Bringing Total to Six Payers Covering GPS ...

Read More >

August 03, 2016

Sanford Health Selects NantHealth's eviti Platform to Deliver Efficient, Evidence-Based Oncology Decision Support for Treatment of Cancer Patients

Major U.S. health system brings award-winning comprehensive clinical decision support to the upper Midwest CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2016-- NantHealth, Inc. (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that Sanford Health, one of the largest health systems in the nation, has entered into a commercial license agreement for the use of its eviti®, the evidence...

Read More >

August 02, 2016

NantHealth to Report 2016 Second-Quarter Financial Results and Host Conference Call on Tuesday, August 9

CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 2, 2016-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2016 second quarter on Tuesday, August 9, 2016 after market close. NantHealth management will host a conference call that same day at 2 p.m. PT (5 p.m. ET) to review the company’s performance and answer questions. The conferen...

Read More >

Upcoming Events
There are currently no events scheduled.